Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01430936 · ClinicalTrials.gov registry record

Evaluate Heart Failure Patients With Specially Designed Patient Adherence and Monitoring Software on Standard Mobile Devices

A clinical trial, sponsored by Aventyn.

Completed
Registry status
51
Enrollment target

NCT01430936 is a clinical trial that has completed, run by Aventyn. The registered enrollment target is 51 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01430936 has completed, sponsored by Aventyn.

COMPLETED
Registry status
51 participants
Enrollment target

Study Summary

This is planned as a feasibility study. The objective is to evaluate a specially designed patient adherence and monitoring software on standard mobile devices in remote monitoring of heart failure patients.

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2011-01
Est. Completion 2012-04

Sponsor

Aventyn

6 total trials

What the Registry Record Tells You About NCT01430936

The ClinicalTrials.gov registry entry for NCT01430936 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Aventyn, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01430936 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01430936 about?

NCT01430936 is a clinical study titled "Evaluate Heart Failure Patients With Specially Designed Patient Adherence and Monitoring Software on Standard Mobile Devices". This is planned as a feasibility study. The objective is to evaluate a specially designed patient adherence and monitoring software on standard mobile devices in remote monitoring of heart failure patients.

What is the current status of trial NCT01430936?

This trial is currently completed. The enrollment target is 51 participants. The study started on 2011-01. Estimated completion is 2012-04.

Who is sponsoring clinical trial NCT01430936?

This trial is sponsored by Aventyn, which has 6 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.